| Dr Jon Kenneth Durham, | |
|
531 7th Ave, Albany, GA 31701-1921 | |
| (229) 883-3535 | |
| (229) 883-3783 |
| Full Name | Dr Jon Kenneth Durham |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 40 Years |
| Location | 531 7th Ave, Albany, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558354761 | NPI | - | NPPES |
| 00301232A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 000522 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany Podiatry Associates, Llp | 5496746117 | 3 |
News Archive
Columbia Laboratories, Inc. today announced it completed enrollment in the PREGNANT (PROCHIEVE Extending GestatioN A New Therapy) Study last week. This randomized, double-blind, placebo controlled Phase III clinical study is evaluating the safety and efficacy of PROCHIEVE® 8% (progesterone gel) to reduce the risk of preterm birth in women with a cervical length between 1.0 and 2.0 centimeters as measured by transvaginal ultrasound at mid-pregnancy.
Performing vascular reconstruction during surgical resection for pancreatic cancer is associated with a greater likelihood of postoperative adverse outcomes than resection alone, say US researchers.
Researchers at Zucker Hillside Hospital's Recognition and Prevention (RAP) Program who have worked with teenagers at risk for serious mental illness for the past decade are now studying the effectiveness of Omega 3 fatty acids (fish oil) for treating psychiatric symptoms.
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.
› Verified 7 days ago
| Provider Name | Albany Podiatry Associates, Llp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821277591 PECOS PAC ID: 5496746117 Enrollment ID: O20040521000093 |
News Archive
Columbia Laboratories, Inc. today announced it completed enrollment in the PREGNANT (PROCHIEVE Extending GestatioN A New Therapy) Study last week. This randomized, double-blind, placebo controlled Phase III clinical study is evaluating the safety and efficacy of PROCHIEVE® 8% (progesterone gel) to reduce the risk of preterm birth in women with a cervical length between 1.0 and 2.0 centimeters as measured by transvaginal ultrasound at mid-pregnancy.
Performing vascular reconstruction during surgical resection for pancreatic cancer is associated with a greater likelihood of postoperative adverse outcomes than resection alone, say US researchers.
Researchers at Zucker Hillside Hospital's Recognition and Prevention (RAP) Program who have worked with teenagers at risk for serious mental illness for the past decade are now studying the effectiveness of Omega 3 fatty acids (fish oil) for treating psychiatric symptoms.
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jon Kenneth Durham, 531 7th Ave, Albany, GA 31701-1921 Ph: (229) 883-3535 | Dr Jon Kenneth Durham, 531 7th Ave, Albany, GA 31701-1921 Ph: (229) 883-3535 |
News Archive
Columbia Laboratories, Inc. today announced it completed enrollment in the PREGNANT (PROCHIEVE Extending GestatioN A New Therapy) Study last week. This randomized, double-blind, placebo controlled Phase III clinical study is evaluating the safety and efficacy of PROCHIEVE® 8% (progesterone gel) to reduce the risk of preterm birth in women with a cervical length between 1.0 and 2.0 centimeters as measured by transvaginal ultrasound at mid-pregnancy.
Performing vascular reconstruction during surgical resection for pancreatic cancer is associated with a greater likelihood of postoperative adverse outcomes than resection alone, say US researchers.
Researchers at Zucker Hillside Hospital's Recognition and Prevention (RAP) Program who have worked with teenagers at risk for serious mental illness for the past decade are now studying the effectiveness of Omega 3 fatty acids (fish oil) for treating psychiatric symptoms.
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.
› Verified 7 days ago
Desiree Dalcherone, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 401 S Madison St, Albany, GA 31701 Phone: 229-405-6959 | |
Lafayette Foot & Leg Specialist Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 2600 W Doublegate Dr, Albany, GA 31721 Phone: 229-436-3056 Fax: 229-346-3056 | |
Xiomara Okonkwo, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 401 S Madison St, Albany, GA 31701 Phone: 229-405-6959 Fax: 229-888-3176 | |
Dr. Glenn Aaron Dowling, Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 531 7th Ave, Albany, GA 31701 Phone: 229-883-3535 Fax: 229-883-3783 | |
Hoang Tran Lafayette, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2600 W Doublegate Dr, Albany, GA 31721 Phone: 229-436-3056 Fax: 229-436-3056 | |
Franklin Chad Catrett, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 531 7th Ave, Albany, GA 31701 Phone: 229-883-3535 Fax: 229-883-3535 |